Overview

A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazole in Healthy Participants

Status:
COMPLETED
Trial end date:
2024-06-17
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the effect of itraconazole on the pharmacokinetic (PK) of baxdrostat.
Phase:
PHASE1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Itraconazole